Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Chen, LF, Arduino, JM, Sheng, S, Muhlbaier, LH, Kanafani, ZA, Harris, AD, Fraser, TG, Allen, K, Corey, GR, and Fowler, VG. "Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type." Am J Infect Control 40, no. 10 (December 2012): 963-968.

PMID
22609237
Full Text

Stryjewski, ME, Potgieter, PD, Li, Y-P, Barriere, SL, Churukian, A, Kingsley, J, Corey, GR, and TD-1792 Investigators Group, . "TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections." Antimicrobial Agents and Chemotherapy 56, no. 11 (November 2012): 5476-5483.

PMID
22869571
Full Text

Stryjewski, ME, Barriere, SL, O'Riordan, W, Dunbar, LM, Hopkins, A, Genter, FC, and Corey, GR. "Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections." J Antimicrob Chemother 67, no. 6 (June 2012): 1496-1502.

PMID
22416054
Full Text

Kanafani, ZA, and Corey, GR. "Tedizolid (TR-701): a new oxazolidinone with enhanced potency." Expert Opinion on Investigational Drugs 21, no. 4 (April 2012): 515-522. (Review)

PMID
22324973
Full Text

Rangwala, F, Putcharoen, O, Bowonwatanuwong, C, Edwards-Jackson, N, Kramomthong, S, Kim, JH, Corey, GR, and Ananworanich, J. "Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review." Southeast Asian J Trop Med Public Health 43, no. 2 (March 2012): 436-441.

PMID
23082594
Scholars@Duke

Nannini, EC, Corey, GR, and Stryjewski, ME. "Telavancin for the treatment of hospital-acquired pneumonia: Findings from the ATTAIN studies." Expert Review of Anti-Infective Therapy 10, no. 8 (2012): 847-854.

PMID
23030322
Full Text

Chow, S-C, Corey, R, and Lin, M. "On the independence of data monitoring committee in adaptive design clinical trials." Journal of Biopharmaceutical Statistics 22, no. 4 (2012): 853-867.

PMID
22651119
Full Text

Corey, GR, and Jones, RN. "Ceftaroline applications for therapy in the United States." Clinical Infectious Diseases 55, no. SUPPL. 3 (2012): S171-S172.

PMID
22903948
Full Text

Rubinstein, E, Corey, GR, and Stryjewski, ME. "Erratum: Reply to Tarchini (Clinical Infectious Diseases (2011) 52 (1391-1392))." Clinical Infectious Diseases 54, no. 2 (2012): 309--.

Full Text

Nienaber, JJC, Sharma Kuinkel, BK, Clarke-Pearson, M, Lamlertthon, S, Park, L, Rude, TH, Barriere, S, Woods, CW, Chu, VH, Marín, M, Bukovski, S, Garcia, P, Corey, GR, Korman, T, Doco-Lecompte, T, Murdoch, DR, Reller, LB, Fowler, VG, and International Collaboration on Endocarditis-Microbiology Investigators, . "Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins." J Infect Dis 204, no. 5 (September 1, 2011): 704-713.

PMID
21844296
Full Text

Pages